O ur results suggest that low-dose SWCNTs may induce fetal malformations, that such an effect is exacerbated by oxidation, and that embryotoxicity of SWCNTs can be reliably predicted by the EST.
In the past few years, carbon nanotubes (CNTs), a class of engineered nanomaterials (ENMs) with versatile physicochemical properties, have attracted much interest for a wide variety of applications, from industry to biomedicine, 1À3 and it can be easily predicted that in the near future many people will come in contact with such material both in the workplace and in the environment. Although the possible consequences of CNT exposure on human health are largely unknown, harmful effects cannot be excluded. In fact, some characteristics of ENMs, like their high surface to volume ratio, may make them potentially more toxic than the micrometric counterpart. 4 In addition, in comparison with other ENMs, intrinsic properties of CNTs might increase their toxicity; the fiber-like shape and low solubility might indeed account for their high biopersistence, 5 possibly exerting long-term adverse effects even after sporadic exposure. Furthermore, differences in the presence of contaminants retained during CNTs synthesis, 6, 7 the deliberate introduction of chemical groups (functionalization), 8 the length, 9, 10 or the presence of defects 11À13 may also influence their toxicity profile. 14 Although several in vivo and in vitro studies on the toxicity of CNTs have been performed in the past few years, 15, 16 a comprehensive knowledge of their effects is still far from being obtained. This gap is even larger concerning their effects on embryonic development, for which only sparse data are available, most of them referring to aquatic species. 17À19 Many studies have focused on the zebrafish embryo due to some advantageous characteristics: its entire developmental phase takes only about four days and takes place outside the mother, allowing a direct visualization of the morphological changes occurring. In such species it has been demonstrated that CNTs do not interfere with proper embryonic development, and the observed hatching delay might be ascribed to Ni and Co contaminants, rather than the CNTs themselves. 17 Despite the advantages of the zebrafish model, fish development and embryo morphology differ from that of mammals, and findings for one class cannot be automatically translated to the other. To our knowledge, no studies have been so far performed on the effects of CNTs on mammalian embryonic development, despite the high potential clinical and social relevance of this end point. The aim of the present study was to assess if the administration of pristine and functionalized singlewall CNTs (SWCNTs) to pregnant mice might adversely affect the development of the postimplantation mouse embryo. In parallel, we have evaluated whether an in vitro test, the embryonic stem cell test 20 
RESULTS AND DISCUSSION
Three types of SWCNTs have been used: pristine (p-SWCNTs), oxidized (o-SWCNTs), and ultraoxidized SWCNTs (uo-SWCNTs). p-and o-SWCNTs were purchased, while uo-SWCNTs were prepared in our laboratory by oxidation of o-SWCNT, according to a procedure previously described. 24 Commercially available nanosized carbon black (n-CB) was used as a nonfibrous, carbon-based control material. Representative transmission electron microscopy (TEM) images of the samples are shown in Figure 1 , and a full characterization of SWCNTs is provided in Table 1 . 
ARTICLE
For further chemical characterization see the Supporting Information (SI). Pristine and oxidized SWCNTs appeared organized in bundles; aggregates of amorphous carbon were also present. Diameter and length were evaluated by high-resolution TEM analysis and are shown in Table 1 . Elemental analysis revealed the presence of Si, S, Fe, Ca, Cr, and Co as main impurities in the pristine samples. In the oxidized samples, metals were present only in traces as a consequence of the oxidative treatments used for their preparation (Table1).
Since metals leached in the cell culture medium might have contributed to the toxic response, the concentration of metals present in the supernatant of medium in which SWCNTs had been kept in suspension for 10 days (the total duration of the in vitro experiments) was measured by AE-ICP analysis. Among the possible contaminants, only cobalt was found to be released in the medium at final concentrations of 34, 5, and 4 μM for p-SWCNTs, o-SWCNTs, and uo-SWCNTs, respectively. In Vivo Exposure of SWCNTs. Each tested nanomaterial was intravenously (iv) injected in the retrobulbar venous plexus of pregnant females at postcoital day 5.5 (5.5 dpc). At 15.5 dpc, animals were sacrificed, and fetuses and placentas were analyzed. The iv administration was preferred to pharyngeal aspiration, as it does not require general anesthesia, which can by itself affect pregnancy.
Injected mice were daily observed for possible acute or delayed side effects related to the injection of nanomaterials. No deaths, clinically relevant disorders, or evident behavioral changes were recorded.
In the first set of experiments, pregnant females were treated with a relatively high dose of each material (30 μg/mouse). At such a dose, all types of SWCNTs, but not n-CB, were able to induce gross fetal morphological abnormalities (Table 2 ). In addition, a substantial percentage of SWCNT-exposed mice (ranging from 19% to 31%) presented swollen uteri (at least twice the diameter of a nonpregnant normal uterus) with no developed embryos ( Table 2 ), a finding never observed in control females and which we interpreted as evidence of early miscarriages. With the aim to identify the concentration of SWCNTs showing no teratogenic or abortive effects, decreasing doses of the materials were used in subsequent experiments. Interestingly, at 3 μg/mouse the percentage of females with early miscarriages greatly decreased, but percentages of mothers with malformed fetuses increased (Table 2) . At further lower dosages (0.3 and 0.1 μg/mouse), no miscarriages were observed, but mothers carrying fetuses with gross malformations were still present, although in much lower percentages (Table 2) . Finally, at the concentration of 0.01 μg/ mouse no miscarriages or fetal malformations were observed ( Table 2) . At all dosages, n-CB or vehicle did not exert any teratogenic or abortive effect. A wide variety of malformations was found ( Figure 2AÀH ), but no differences in their type and severity were observed among the three groups of CNTs and among different concentrations within each group. In some cases the fetuses appeared morphologically normal, but significantly growth retarded ( Figure 2E ); more often, fetuses with abdominal wall or head deformities or limb hypoplasia ( Figure 2BÀD and F) were observed. In more abnormal fetuses, a severe retardation in the development of several organs and tissues was associated with an abnormal torsion of the trunk (Figure 2G ), or the body plan was profoundly affected 
and the outlines of the fetus could be barely identified ( Figure 2H ). In a small set of experiments, females were treated with low doses of SWCNTs (0.3 and 0.1 μg/mouse) at the peri-implantation stage (between day 4.5 and 5 of gestation). Interestingly, in p-and uo-SWCNT-treated females, besides the presence of malformations, a few fetuses were found to share the same placenta ( Figure 2I and L). In 80% of the twinning events, we observed intertwin discordance, encompassing fetal size, feto-placental hemodynamics, and structural defects. Such features resemble vascular pathologies that can complicate monochorial twin pregnancies in humans, such as the "twin to twin transfusion syndrome" and the "twin reversed arterial perfusion sequence" ( Figure 2I and L). In both complications one of the twins is developmentally retarded due to blood transfusion via placental vascular anastomosis between the two circulations. 25, 26 Analysis of the gonads revealed that fetuses attached to the same placenta were always of the same sex, a further indication of monozygotic twinning. Monozygotic twinning is an extremely rare event in mice, and in mammals it is widely accepted that its occurrence is a consequence of teratogenic stimuli, 27 thus indicating that the observed twins might be a result of the teratogenic effect of SWCNTs.
No monozygotic twinning was ever observed in n-CBand vehicle-treated females.
At macroscopic analysis, all placentas from malformed fetuses appeared abnormal, whereas no alteration was detected in placentas from normal fetuses. In detail, abnormal placentas presented obvious alterations in size and vascular organization of the labyrinth layer ( Figure 3AÀC ), characterized by disruption of the ARTICLE radial distribution and arborization of the placental vascular bed. Immuno-histochemical analysis using antibodies against the pan-endothelial marker CD31 ( Figure 3D and E) and Azan-Mallory staining ( Figure 3F and G) showed strongly reduced vessel density and branching, as well as areas of fibrin deposition, reflecting the presence of thrombotic vessels. Interestingly, this evident vascular damage, which has never been previously reported in other organs at such very low doses, may be a consequence of the massive angiogenesis occurring in the developing placenta. To verify the hypothesis that the placenta might be particularly vulnerable to exposure to SWCNTs, we performed histological and immuno-histochemical analysis of maternal tissues (liver, lung, kidney, and spleen). No evident tissue alterations were detected ( Figure S6 of the SI), suggesting that in our experimental conditions the placenta and fetus are mainly affected by the systemic injection of SWCNTs.
The clear association between SWCNT exposure and placental-fetal abnormalities prompted us to evaluate whether SWCNTs could be detected in such tissues, to support the evidence of a direct toxic effect of the nanomaterials. To this end, placentas and fetuses from mothers exposed to the highest dose of SWCNTs (30 μg/mouse) were analyzed by histological and micro-Raman analyses ( Figure S5 of the SI). Neither technique was able to confirm the presence of SWCNTs in the samples. It should be considered, however, that we did not detect SWCNTs in any of the maternal tissues, including lung, liver, and kidney, in which the highest accumulation would be expected ( Figure S5 in the SI). 28, 29 Identification of SWCNTs by Raman and histological analyses has been previously reported, in experiments in which much higher amounts of material had been administered to the animals. 29 To find out the resolution limit of our detection system, we performed experiments in which increasing amounts of SWCNTs were added to tissue homogenates before Raman spectroscopy analysis. The calculated detection limit was 15 μg/mL, corresponding to 0.15 μg/mg of tissue; therefore with the highest dosage injected (30 μg/mouse), we can reach at the maximum a theoretical concentration of 0.001 μg/mg, which is well below the detection limit of the technique. A recognized mechanism through which SWCNTs exert their toxicity is represented by oxidative stress. 30 Several in vivo and in vitro studies have demonstrated that SWCNTs are able to induce oxidative stress in endothelial arterial cells, leading to inflammatory cell infiltration and platelet-thrombus formation. 31, 32 In addition, it is widely recognized that placental and embryonic tissues are particularly sensitive to oxidative stress, as a consequence of the high cell proliferation rate and concomitant exposure of DNA. 33 For such reasons it has been proposed that the physiological hypoxia characterizing the first trimester of human gestation might be a way to protect the fetus from teratogenic effects of reactive oxygen species (ROS). 34 The presence of extensive vascular alterations and of thrombi in our model system ( Figure 3DÀG ) led us to hypothesize that placental damage might be a consequence of oxidative stress. ROS generation was therefore assessed in tissue homogenates from uo-SWCNT-treated mothers using dichlorofluorescein-diacetate (DCFDA), a nonfluorescent dye that is oxidized by a variety of ROS to form the highly fluorescent dichlorofluorescein (DCF). ROS were significantly higher in homogenates of placentas from malformed fetuses as compared to samples from vehicle-or ARTICLE n-CB-exposed mothers ( Figure 4A ). Interestingly, ROS levels were also significantly higher in malformed fetuses ( Figure 4B ). The occurrence of oxidative stress was evaluated in maternal tissues as well (liver, lung, kidney, and spleen), but no evident differences were observed between exposed and control mice (data not shown).
Embryonic Stem Cell Test. The use of animal testing for routine screening of toxicity of different compounds is time and money consuming and may raise ethical issues. The development of reliable in vitro models would represent a valuable alternative for screening nanomaterial embryotoxicity. The EST is a validated test for predicting embryotoxicity of chemical compounds, 20, 21 and its extension to nanomaterials would be of great importance for evaluating their embryotoxicity without making use of animal studies.
To this end, in parallel to the in vivo studies, reliability of the EST for predicting SWCNT embryotoxicity was investigated. In the EST two stable cell lines are used: NIH3T3 fibroblasts (representing differentiated tissue) and mouse embryonic stem (mES) cells (representing embryonic tissue). Three end points are obtained from doseÀresponse curves after 10 days of culture: (i) 50% inhibition of differentiation of mES cells into contracting myocardial cells (ID 50 ), as assessed by morphological analysis of beating cell areas (contracting embryoid bodies, EBs); (ii) 50% inhibition of proliferation of mES (IC 50ES ) and (iii) of NIH3T3 cells (IC 503T3 ). An algorithm eventually integrates these three values to obtain an evaluation of predicted embryotoxicity. As required by the EST standardized protocol, 20, 21 due to the higher sensitivity of mES to toxic agents, as compared to NIH3T3 differentiated cells, different concentrations of the tested compound are to be used for the two cell lines in order to obtain 
the IC 50 values. In our experiment, the effect of SWCNTs on cell proliferation was studied by growing the cells in medium containing the same carbon compounds used in the in vivo experiments, at concentrations between 0.1 and 10 μg/mL for mES cells and 1 and 100 μg/mL for NIH3T3 cells. After 10 days of culture, cell viability was measured by a colorimetric assay (WST-1) and the IC 50 values were calculated for each carbon compound in each cell line ( Figure 5A and B). The ID 50 was obtained by culturing mES cells under conditions stimulating differentiation into EBs in the presence of nanoparticle concentrations ranging from 0.1 to 10 μg/mL. For each material, no significant decrease of mES cell viability was observed at 0.1 μg/mL; o-and uo-SWCNTs decreased viability to about 70% and 60%, respectively, at 1 μg/mL, to less than 40% at 2 μg/mL, and down to approximately zero at higher concentrations. The calculated IC 50ES for o-and uo-SWCNTs was 1.41 and 1.20 μg/mL, respectively. The effect of p-SWCNT exposure was first detected at 2 μg/mL, and only at the highest dose (10 μg/mL) was it comparable to what was observed for the oxidized materials. For such material the IC 50ES was 4.36 μg/mL. n-CB showed no significant effect on mES at any of the tested doses. A different pattern was observed with NIH3T3 cells; for each tested material no effect was detected up to 10 μg/mL, a dose killing almost 100% of mES. For such reasons, in order to obtain the IC 503T3 value, higher concentrations were tested. At 20 μg/mL uo-SWCNT exposure caused a sharp decrease in viability (down to 30%), and almost no cell survival was recorded at 30 μg/mL. The other three types of materials showed a similar pattern, with a progressive decrease in viability starting at 20 μg/mL and reaching the same level as uoSWCNTs at the highest dose.
Regarding the effect of the four tested materials on mES differentiation into contracting EBs, n-CB was ineffective up to 3 μg/mL, and the percentage of contracting EBs was decreased to 55% at the highest dose (ID 50 not measurable). By contrast, the three types of SWCNTs showed a marked inhibitory effect starting at 6 μg/mL, with contracting EBs being reduced to about 20%. At the highest dose (10 μg/mL) almost no contracting EBs were detected. The calculated ID 50 values for p-, o-, and uo-SWCNTs were 4.1, 3.85, and 3.2 μg/mL, respectively.
The EST algorithm classified all three types of SWCNTs as "strong embryotoxic". By contrast, the IC 50 ES and ID 50 for n-CB were above the tested range, so that no classification was possible for such nanomaterial. These findings are in accordance with the in vivo results, thus suggesting that the EST, currently used for predicting embryotoxicity of soluble chemical compounds, may have the same accuracy for nanomaterials. Very few and partial attempts to apply the EST to other nanoparticles have been reported, 22, 23 and none of such studies have matched in vitro data to in vivo data. To date, this is the first time that the full EST protocol has been applied to the study of nanomaterials.
The possible leakage to the medium of contaminants from SWCNTs might have affected our results. To verify this hypothesis, we performed a set of experiments in which ES and NIH3T3 cells were cultured in SWCNT-conditioned medium (see SI). No effect on viability of the two cell lines or development of contracting EBs was observed, as compared to control medium ( Figure S7 ). These findings suggest a negligible effect on the in vitro results of contaminants released from SWCNTs.
CONCLUSION
Our in vitro and in vivo results suggest that SWCNTs may act as embryotoxic agents in mammals. The concordance of in vitro and in vivo data is generally considered as an important issue when assessing toxicological properties of any material, since validation of the in vitro findings may allow further in vivo studies to be drastically reduced or omitted.
In the in vivo experiments, teratogenicity was still observed at a dosage as low as of 100 ng/mouse. On the basis of data from the literature on the biodistribution of SWCNTs, 29, 35 it is reasonable to assume that only a minor fraction of the injected material may reach the placenta and the fetus. The lowest dose found to be effective in the present study is several orders of magnitude lower than what has been previously reported in other toxicological experiments, with different end points. As an example, pro-carcinogenic properties of CNTs have been suggested by a study in which a 500 times higher amount was directly injected into the target tissue. 10 Our findings therefore suggest that the fetus is highly susceptible to the exposure to these materials. We could not discriminate between a direct or indirect effect of SWCNTs to the placenta and/or the fetus, since the nanotubes were not detectable in such tissues, probably due to the low administered dose. However, an oxidative damage, typically linked to SWCNT pathogenic mechanisms, 30 was observed in both malformed placentas and fetuses. Further studies might be performed, evaluating whether and at which dosage the in vivo direct injection in the placenta of SWCNTs may reproduce the findings observed in our experiment. Although no differences in the type and severity of malformations were detected in fetuses exposed to the three different classes of SWCNTs, a higher frequency of fetal malformations was observed in uo-SWCNTtreated mothers. Since the functionalization process strongly reduces the presence of contaminants, which are considered as one of the main players in nanoparticle toxicity, the most marked embryotoxic effect of uo-SWCNTs seems to be determined by some intrinsic physicochemical characteristics of the material itself. A ARTICLE higher toxicity of oxidized, as compared to pristine, CNTs has been previously reported for both in vitro and in vivo models, 8, 36, 37 and it is usually ascribed to a better dispersion of the material in the medium and its consequent higher bioavailability. 8, 36, 37 Although we observed a similar size distribution of aggregates between pristine and oxidized SWCNTs, we cannot exclude that monodispersed SWCNTs were more abundant in oxidized SWCNTs. Apart from dispersion, the higher negative charge and hydrophilicity of oxidized CNTs, which is a consequence of the introduction of oxygenated functionalities, may also play a role. 37 The pathophysiologic mechanism by which SWCNTs adversely affect pregnancy has been only partially explored in the present study, but the strict association between embryonic developmental retardation and placental damage suggests a role of the placenta in mediating the embryotoxic effect. Our in vitro studies, however, show that embryonic tissues are strongly sensitive to SWCNT damage, and therefore a direct effect on the embryo in vivo may be hypothesized. Evidence that nanoparticles can cross the bloodÀplacental barrier has been reported. 38, 39 These data, however, refer to polystyrene beads and gold nanoparticles and cannot be directly applied to SWCNTs, given the different shape and length of these nanomaterials. Data on the ability of SWCNTs to cross the placental barrier are needed.
In conclusion, our results suggest that exposure to SWCNTs may represent a potential risk for pregnant women, especially in the occupational setting, where the risk of accidental exposure may become real in light of the foreseen increased production of ENM in the near future.
Further studies are needed in order to fully understand the underlying mechanism by which CNTs (especially oxidized CNTs) can induce embryotoxicity and to confirm the reliability of the EST in predicting embryotoxicity for other ENMs.
MATERIALS AND METHODS
Materials and Reagents. p-SWCNT and o-SWCNTs were purchased from Cheap Tubes Inc. (Brattleboro, VT). Carbon black was purchased from Cabot Corporation (Boston, MA). All reagents were of analytical grade and were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise specified. Deionized water was produced by a Milli-Q system (Millipore, Billerica, MA) and was used for all chemical procedures.
Preparation of uo-SWCNTs. uo-SWCNTs were prepared by acidic treatment of the commercially available o-SWCNTs. In details, o-SWCNTs were treated with a solution of HNO 3 /H 2 SO 4 1:3 (v/v), for 8 h at 50°C, in an ultrasonic bath (at 50 W). After the treatment, the powder was washed with bidistilled water and separated by centrifugation until neutrality was reached. Finally, the powder was dried overnight at 100°C and stored at room temperature in a tightly closed vial.
Morphological Characterization. Morphological characterization of the three types of SWCNTs and n-CB was performed by transmission electron microscopy (Philips, CM120, with a LaB6 filament, 100 kV). For the analysis, nanomaterial powders were first dispersed in ethanol (1 mg/5 mL) using an ultrasonic bath for 1 h at room temperature. A perforated carbon Formvar film supported by copper grids (j = 3 mm) was dipped in the suspensions for a few seconds and the solvent evaporated under an infrared lamp. The substrate was then assembled on aluminum stubs with carbon tape.
In order to clearly distinguish between bundles of SWCNTs and single tubes, the length was measured at a magnification of 31 000Â. With such a method CNTs that cross the borders of the visual field cannot be considered, so that the overall length of the three types of SWCNTs might have been underestimated. Length was calculated as the mean of SWCNTs that were entirely present in the visual field ((SD).
In Vivo Experimental Procedures. All animal procedures were approved by the Institutional Animal Care and Use Committee and comply with European rules (116/92). Animals used in the present study were six to eight week old females of the CD1 outbred strain (Charles River, Calco, Italy), considered as a general multipurpose model for in vivo studies. All animals were housed and mated under standard laboratory conditions. Their weight was between 30 and 35 g. Females at day 5.5 of gestation were injected in the retrobulbar plexus with n-CB, p-, o-, uo-SWCNTs (stock solutions of 1 mg/mL in DMEM containing 10 mg/mL BSA), or control medium (DMEM-BSA). Saline solution was used to adjust the final injection volume to 100 μL.
The retrobulbar injection is a valuable alternative to the tail vein injection route and is recommended for small laboratory animals. 40 Such procedure is much less technically challenging than tail vein injection, and to an experienced operator no anesthesia is required, as hand restraint is sufficient; in addition, there is no need for warming preparation of the animal, and the whole procedure is only a matter of seconds. In our experiments, the mouse was immobilized on absorbent paper, keeping it motionless. Using a 1 cc syringe and a 27 gauge needle, a volume of 100 μL was gently injected in the center of the retroorbital sinus of the right eye. No local complications related to the procedure were observed. Ten days later, control and treated females were euthanized by carbon dioxide, and fetuses and their placentas collected and analyzed for the presence of malformations under a stereomicroscope. Fetuses that presented evident morphological abnormalities were photographed and then fixed with their placentas in 4% paraformaldehyde together with a morphologically normal sibling for subsequent histochemical and immuno-histochemical analysis. In parallel, fetuses and placentas from control mothers were analyzed.
Histochemical and Immuno-histochemical Analysis. Fetuses and placentas were processed for paraffin embedding, following standard procedures. Five-micrometer sections of placentas from normal and malformed fetuses were stained with Azan Mallory in order to visualize the presence of fibrin deposition. 41 Parallel sections were immuno-stained with anti-CD31 antibodies (BD Biosciences, Franklin Lakes, NJ) to outline the vascular network. Further experimental details are reported in the Supporting Information.
Cell Culture. Mouse ES cell line D3 and NIH3T3 cells were purchased from ATCC (America Type Tissue Collection, Manassas, VA). Both cell lines were maintained in culture following standard protocols (for details see SI). For proliferation assay experiments, 500 mES or NIH3T3 cells were plated in each well of a 96-well plate in the presence of different concentration of the three types of SWCNTs, of n-CB or BSA. For mES cells the concentrations tested were 0.1, 1, 2, 6, and 10 μg/mL; for NIH3T3 cells 10 times higher concentrations were used. On day 10, proliferation of the cells was evaluated using the WST-1 colorimetric assay following the manufacturer's specifications (Cell Proliferation Reagent WST-1, Roche Diagnostics, Indianapolis, IN) (for details see SI). Due to the production of water-soluble formazan salts, such test has been proven compatible with the use of SWCNTs. 42 For mES cell differentiation into embryoid bodies the "hanging drops" protocol was followed according to ARTICLE the EST guidelines. On day 10 the presence of spontaneous contraction of the embryoid bodies was visually evaluated under the light microscope. Further experimental details are reported in the Supporting Information.
Evaluation of Oxidative Stress. Production of ROS was measured in tissue homogenates by the conversion of nonfluorescent 2 0 ,7 0 -dichlorofluorescein-diacetate to the highly fluorescent 2 0 ,7 0 -dichlorofluorescein. Briefly, the assay measures the oxidative conversion of stable, nonfluorescent DCF-DA to the highly fluorescent DCF in the presence of esterases and ROS. 43 Tissues were homogenized in homogenization buffer (20 mM glycerophosphate, 20 mM NaF, 2 mM sodium orthovanadate, 1 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, 1 mM pepstatin, 80 mg/L trypsin inhibitor, and 100 mM Tris-Cl, pH 7.4) and centrifuged at 900g at 4°C for 15 min. The supernatants were further centrifuged at 12000g for an additional 15 min and were assayed for protein content by the BioRad protein assay method (BioRad Laboratories GmbH, Munchen, Germany). A 100 μg amount of proteins of each sample was incubated with a final concentration of 25 μM DCF-DA in a 96-well plate at 37°C. Measurements were taken at 0 and 30 min with excitation and emission wavelengths of 495 and 530 nm, respectively, using a SPECTRAmax GEMINI-XS microplate fluorescence reader (Molecular Devices, Sunnyvale, CA). Values are expressed as relative fluorescence units (RFU) normalized per milligram of protein.
